Therefore, the suppressive effects of AMPK signalling on glycolytic phenotype require the presence and the activation of tumour suppressive mechanisms mediated by p53, PTEN, TSC, and LKB1, but since they are frequently inactivated in cancers, the expression of the Warburg phenotype is promoted [37]. This evidence concerns the gene PTEN and neoplasm.